Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Feb;79(2):483–491. doi: 10.1172/JCI112838

Human giant cell tumors of bone identification and characterization of cell types.

S R Goldring, M S Roelke, K K Petrison, A K Bhan
PMCID: PMC424109  PMID: 3027126

Abstract

Cells cultured from human giant cell tumors of bone were characterized on the basis of morphological features, proliferative capacity, presence of granulocyte-monocyte antigens, receptors for skeletal hormones, and soluble cell products. Three major cell types were identified. One population consisted of mononuclear cells with fibroblastic morphology, which proliferated in culture and most likely represent the neoplastic element of the tumor. Phenotypically they resembled a connective tissue stromal cell. A second population of mononuclear cells lacked receptors for skeletal hormones and did not persist in culture. These cells were likely of monocyte-macrophage lineage. A third population of cells consisted of large multinucleated giant cells. These cells possessed phenotypic features of osteoclasts including receptors for calcitonin. Human giant cell tumors of bone are most likely a neoplasm of connective tissue stromal cells, which have the capacity to recruit and interact with multinucleated giant cells that exhibit phenotypic features of osteoclasts.

Full text

PDF
483

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alitalo K., Hovi T., Vaheri A. Fibronectin is produced by human macrophages. J Exp Med. 1980 Mar 1;151(3):602–613. doi: 10.1084/jem.151.3.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amento E. P., Bhan A. K., McCullagh K. G., Krane S. M. Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. J Clin Invest. 1985 Aug;76(2):837–848. doi: 10.1172/JCI112041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aparisi T., Arborgh B., Ericsson J. L. Giant cell tumor of bone: detailed fine structural analysis of different cell components. Virchows Arch A Pathol Anat Histol. 1977 Dec 8;376(4):273–298. doi: 10.1007/BF00432299. [DOI] [PubMed] [Google Scholar]
  4. Aparisi T., Arborgh B., Ericsson J. L. Giant cell tumor of bone: fine structural localization of acid phosphatase. Virchows Arch A Pathol Anat Histol. 1977 Dec 8;376(4):299–308. doi: 10.1007/BF00432300. [DOI] [PubMed] [Google Scholar]
  5. Bhan A. K., DesMarais C. L. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. J Natl Cancer Inst. 1983 Sep;71(3):507–516. [PubMed] [Google Scholar]
  6. Bonner W. M., Laskey R. A. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem. 1974 Jul 1;46(1):83–88. doi: 10.1111/j.1432-1033.1974.tb03599.x. [DOI] [PubMed] [Google Scholar]
  7. Burmester G. R., Winchester R. J., Dimitriu-Bona A., Klein M., Steiner G., Sissons H. A. Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens. J Clin Invest. 1983 Jun;71(6):1633–1648. doi: 10.1172/JCI110919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Byers V. S., Levin A. S., Johnston J. O., Hackett A. J. Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma. Cancer Res. 1975 Sep;35(9):2520–2531. [PubMed] [Google Scholar]
  9. Chambers T. J., Fuller K., McSheehy P. M., Pringle J. A. The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells. J Pathol. 1985 Apr;145(4):297–305. doi: 10.1002/path.1711450403. [DOI] [PubMed] [Google Scholar]
  10. Dahlin D. C., Cupps R. E., Johnson E. W., Jr Giant-cell tumor: a study of 195 cases. Cancer. 1970 May;25(5):1061–1070. doi: 10.1002/1097-0142(197005)25:5<1061::aid-cncr2820250509>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  11. FISCHMAN D. A., HAY E. D. Origin of osteoclasts from mononuclear leucocytes in regenerating newt limbs. Anat Rec. 1962 Aug;143:329–337. doi: 10.1002/ar.1091430402. [DOI] [PubMed] [Google Scholar]
  12. Franklin W. A., Mason D. Y., Pulford K., Falini B., Bliss E., Gatter K. C., Stein H., Clarke L. C., McGee J. O. Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest. 1986 Mar;54(3):322–335. [PubMed] [Google Scholar]
  13. Goldenberg R. R., Campbell C. J., Bonfiglio M. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am. 1970 Jun;52(4):619–664. [PubMed] [Google Scholar]
  14. Goldring S. R., Dayer J. M., Ausiello D. A., Krane S. M. A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressin. Biochem Biophys Res Commun. 1978 Jul 28;83(2):434–440. doi: 10.1016/0006-291x(78)91009-4. [DOI] [PubMed] [Google Scholar]
  15. Goldring S. R., Dayer J. M., Krane S. M. Regulation of hormone-induced cyclic AMP response to parathyroid hormone and prostaglandin E2 in cells cultured from human giant cell tumors of bone. Calcif Tissue Int. 1979;29(3):193–200. doi: 10.1007/BF02408080. [DOI] [PubMed] [Google Scholar]
  16. Goldring S. R., Dayer J. M., Krane S. M. Rheumatoid synovial cell hormone responses modulated by cell-cell interactions. Inflammation. 1984 Mar;8(1):107–121. doi: 10.1007/BF00918358. [DOI] [PubMed] [Google Scholar]
  17. Goldring S. R., Dayer J. M., Russell R. G., Mankin H. J., Krane S. M. Cells cultured from human giant cell tumors of bone respond to parathyroid hormone. Calcif Tissue Res. 1977 May;22 (Suppl):269–274. doi: 10.1007/BF02064078. [DOI] [PubMed] [Google Scholar]
  18. Goldring S. R., Dayer J. M., Russell R. G., Mankin H. J., Krane S. M. Response to hormones of cells cultured from human giant cell tumors of bone. J Clin Endocrinol Metab. 1978 Mar;46(3):425–433. doi: 10.1210/jcem-46-3-425. [DOI] [PubMed] [Google Scholar]
  19. Goldring S. R., Mahaffey J. E., Rosenblatt M., Dayer J. M., Potts J. T., Jr, Krane S. M. Parathyroid hormone inhibitors: comparison of biological activity in bone- and skin-derived tissue. J Clin Endocrinol Metab. 1979 Apr;48(4):655–659. doi: 10.1210/jcem-48-4-655. [DOI] [PubMed] [Google Scholar]
  20. Goldring S. R., Roelke M. S., Bringhurst F. R., Rosenblatt M. Differential effects of parathyroid hormone responsive cultured human cells on biological activity of parathyroid hormone and parathyroid hormone inhibitory analogues. Biochemistry. 1985 Jan 15;24(2):513–518. doi: 10.1021/bi00323a040. [DOI] [PubMed] [Google Scholar]
  21. Goldring S. R., Schiller A. L., Mankin H. J., Dayer J. M., Krane S. M. Characterization of cells from human giant cell tumors of bone. Clin Orthop Relat Res. 1986 Mar;(204):59–75. [PubMed] [Google Scholar]
  22. Goldring S. R., Tyler G. A., Krane S. M., Potts J. T., Jr, Rosenblatt M. Photoaffinity labeling of parathyroid hormone receptors: comparison of receptors across species and target tissues and after desensitization to hormone. Biochemistry. 1984 Jan 31;23(3):498–502. doi: 10.1021/bi00298a015. [DOI] [PubMed] [Google Scholar]
  23. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  24. Hanaoka H., Friedman B., Mack R. P. Ultrastructure and histogenesis of giant-cell tumor of bone. Cancer. 1970 Jun;25(6):1408–1423. doi: 10.1002/1097-0142(197006)25:6<1408::aid-cncr2820250622>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  25. Horton M. A., Lewis D., McNulty K., Pringle J. A., Chambers T. J. Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res. 1985 Nov;45(11 Pt 2):5663–5669. [PubMed] [Google Scholar]
  26. Horton M. A., Pringle J. A., Chambers T. J. Identification of human osteoclasts with monoclonal antibodies. N Engl J Med. 1985 Apr 4;312(14):923–924. doi: 10.1056/NEJM198504043121418. [DOI] [PubMed] [Google Scholar]
  27. Horton M. A., Rimmer E. F., Lewis D., Pringle J. A., Fuller K., Chambers T. J. Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol. 1984 Dec;144(4):281–294. doi: 10.1002/path.1711440410. [DOI] [PubMed] [Google Scholar]
  28. Hull R. N., Cherry W. R., Weaver G. W. The origin and characteristics of a pig kidney cell strain, LLC-PK. In Vitro. 1976 Oct;12(10):670–677. doi: 10.1007/BF02797469. [DOI] [PubMed] [Google Scholar]
  29. JEE W. S., NOLAN P. D. ORIGIN OF OSTEOCLASTS FROM THE FUSION OF PHAGOCYTES. Nature. 1963 Oct 19;200:225–226. doi: 10.1038/200225a0. [DOI] [PubMed] [Google Scholar]
  30. JEFFREE G. M., PRICE C. H. BONE TUMOURS AND THEIR ENZYMES. A STUDY OF THE PHOSPHATASES, NON-SPECIFIC ESTERASES AND BETA-GLUCURONIDASE OF OSTEOGENIC AND CARTILAGINOUS TUMOURS, FIBROBLASTIC AND GIANT-CELL LESIONS. J Bone Joint Surg Br. 1965 Feb;47:120–136. [PubMed] [Google Scholar]
  31. Johnston J. Giant cell tumor of bone. The role of the giant cell in orthopedic pathology. Orthop Clin North Am. 1977 Oct;8(4):751–770. [PubMed] [Google Scholar]
  32. Kahn A. J., Simmons D. J. Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue. Nature. 1975 Nov 27;258(5533):325–327. doi: 10.1038/258325a0. [DOI] [PubMed] [Google Scholar]
  33. Larsson S. E., Lorentzon R., Boquist L. Giant-cell tumor of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer Registry for the years 1958 through 1968. J Bone Joint Surg Am. 1975 Mar;57(2):167–173. [PubMed] [Google Scholar]
  34. McGrath P. J. Giant-cell tumour of bone: an analysis of fifty-two cases. J Bone Joint Surg Br. 1972 May;54(2):216–229. [PubMed] [Google Scholar]
  35. Nicholson G. C., Moseley J. M., Sexton P. M., Mendelsohn F. A., Martin T. J. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest. 1986 Aug;78(2):355–360. doi: 10.1172/JCI112584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Poulter L. W., Duke O., Hobbs S., Janossy G., Panayi G. Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritic synovial lining. Clin Exp Immunol. 1982 May;48(2):381–388. [PMC free article] [PubMed] [Google Scholar]
  37. Shifrin L. Z. Giant cell tumor of bone. Clin Orthop Relat Res. 1972 Jan-Feb;82:59–66. [PubMed] [Google Scholar]
  38. Steiner G. C., Ghosh L., Dorfman H. D. Ultrastructure of giant cell tumors of bone. Hum Pathol. 1972 Dec;3(4):569–586. doi: 10.1016/s0046-8177(72)80007-8. [DOI] [PubMed] [Google Scholar]
  39. Thomson B. M., Saklatvala J., Chambers T. J. Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med. 1986 Jul 1;164(1):104–112. doi: 10.1084/jem.164.1.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Villiger B., Kelley D. G., Engleman W., Kuhn C., 3rd, McDonald J. A. Human alveolar macrophage fibronectin: synthesis, secretion, and ultrastructural localization during gelatin-coated latex particle binding. J Cell Biol. 1981 Sep;90(3):711–720. doi: 10.1083/jcb.90.3.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wood G. W., Neff J. R., Gollahon K. A., Gourley W. K. Macrophages in giant cell tumours of bone. J Pathol. 1978 May;125(1):53–58. doi: 10.1002/path.1711250108. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES